SCHEMBL20515329

SCHEMBL20515329

Cc1nc2ccc(Br)cc2cc1-c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB5 P28074 6/20 0.71
PRNP P04156 2/20 0.50
RXFP1 Q9HBX9 2/20 0.50
PPARG P37231 1/20 0.50
NR2E3 Q9Y5X4 1/20 0.50
NCOR2 Q9Y618 1/20 0.50
ALDH1A1 P00352 1/20 0.49
ADORA3 P0DMS8 1/20 0.43
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43
ADORA1 P30542 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
ATM Q13315 1/20 0.42
CYP1A2 P05177 2/20 0.42
CYP2C9 P11712 2/20 0.42
CYP2C19 P33261 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
PDE10A Q9Y233 1/20 0.41
CASP3 P42574 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20515344 0.83 PSMB5 (1.00) PSMB5ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL7071941 0.80 PSMB5 (0.71) PSMB5ALDH1A1MEN1KMT2AATM
SCHEMBL1786939 0.80 PSMB5 (0.45) PSMB5PRNPRXFP1PPARGNR2E3
SCHEMBL790060 0.80 FGFR1 (0.54) PSMB5PRNPRXFP1ADORA3ADORA2A
SCHEMBL22919305 0.80 PSMB5 (0.71) PSMB5ALDH1A1MEN1KMT2AATM
SCHEMBL15646572 0.80 HPGD (0.54) PSMB5PRNPRXFP1ALDH1A1MEN1
SCHEMBL28175734 0.79 PSMB5 (0.79) PSMB5ALDH1A1MEN1KMT2ACYP1A2
SCHEMBL28536639 0.78 PDE10A (0.69) PSMB5PRNPRXFP1PPARGNR2E3
SCHEMBL20515351 0.78 PSMB5 (1.00) PSMB5MEN1KMT2ACYP1A2CYP2C9
SCHEMBL20515387 0.78 PSMB5 (0.67) PSMB5ALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114269720-B Acetyl-coa synthetase short chain2(ACSS2) Small molecule inhibitors of (a) 库拉德夫制药私人有限公司 2025-03-28 CN disclosed
US-12084421-B2 Quinoline-based proteasome inhibitors and uses thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2024-09-10 US disclosed
US-20220298115-A1 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) CURADEV PHARMA PVT. LTD. (IN) 2022-09-22 US disclosed
EP-4003961-A2 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) Curadev Pharma Pvt. Ltd. (IN) 2022-06-01 EP disclosed
CN-114269720-A acetyl-CoA synthetase short chains2(ACSS2) Small molecule inhibitors of 库拉德夫制药私人有限公司 2022-04-01 CN disclosed
US-20220048861-A1 QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2022-02-17 US disclosed
WO-2021014415-A2 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) CURADEV PHARMA PVT. LTD. (IN) 2021-01-28 WO disclosed
WO-2021014415-A2 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) CURADEV PHARMA PVT. LTD. (IN) 2021-01-28 WO disclosed
US-20200347019-A1 QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY 2020-11-05 US disclosed
US-10752590-B2 Quinoline-based proteasome inhibitors and uses thereof BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2020-08-25 US disclosed
US-20180282280-A1 QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF NATIONAL SCIENCE FOUNDATION 2018-10-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12084421-B2 Quinoline-based proteasome inhibitors and uses thereof PSME1, PSMB1, PSME3 PSMB5 4/4885PRNP 1652/4885RXFP1 4105/4885
US-20180282280-A1 QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF PSME1, PSMB1, PSME3 PSMB5 4/4885PRNP 1652/4885RXFP1 4105/4885
US-20220048861-A1 QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF PSME1, PSMB1, PSME3 PSMB5 4/4885PRNP 1652/4885RXFP1 4105/4885
US-10752590-B2 Quinoline-based proteasome inhibitors and uses thereof PSME1, PSMB1, PSME3 PSMB5 4/4885PRNP 1652/4885RXFP1 4105/4885
US-20220298115-A1 SMALL MOLECULE INHIBITORS OF ACETYL COENZYME A SYNTHETASE SHORT CHAIN 2 (ACSS2) ACSS2, ACAT1, FADS1 PSMB5 2946/4885PRNP 1791/4885RXFP1 4631/4885
US-20200347019-A1 QUINOLINE-BASED PROTEASOME INHIBITORS AND USES THEREOF PSME1, PSMB1, PSME3 PSMB5 4/4885PRNP 1652/4885RXFP1 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.